“Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization, by the Milken institute.
Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization.
The Milken Institute has released an in-depth examination of the world’s leading universities for biotechnology research and technology transfer, meaning the ability of those universities to turn their intellectual property into commercial applications.
This examination of the commercialization of university research reveals that the U.S. dominates the top rankings on many key measures, including published research, patents issued and licensing income.
The study, Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization, key findings:
– Research activity has a high rate of return. Each 10-point increase in the Institute’s score for published research contributes an additional $1.7 million to a university’s annual licensing income.
– For every $1 invested in an office of technology transfer (OTT) staff, the university receives more than $6 in licensing income.
– For each additional year that an OTT is in operation, $228,000 of incremental licensing income is generated for the university.
Download the full report from The Milken Institute website
Source: The Milken Institute
10 January 2023
Workshop #3: Reducing Pharmaceutical Residuals in the Baltic Sea Region – Comparative Analysis and Assessment of Possibilities | 9 February at 11:00-15:05 EET
4 January 2023
EDAH - a new European project ahead